Nimotuzumab plus chemoradiotherapy shows deliverable safety profile in cervical cancer study
A single-arm exploratory study reports an 88.2 percent 12-week objective response rate and preliminary two-year survival estimates for nimotuzumab added ...
Tag: concurrent chemoradiotherapy
Fitness measure flags esophageal cancer patients unlikely to respond to chemoradiotherapy
A pilot study of 84 esophageal cancer patients found that the oxygen uptake efficiency slope predicted non-response to concurrent chemoradiotherapy ...
Immunotherapy Before Standard Treatment Shows Striking Results in Nasopharyngeal Cancer
A prospective Chinese study found that adding the immunotherapy drug camrelizumab to induction chemotherapy before concurrent chemoradiotherapy produced high complete ...
Predicting Radiation Dermatitis in Head, Neck Cancer
In a groundbreaking study published in BMC Cancer, researchers have developed a highly predictive nomogram model designed to assess the ...
Toripalimab Boosts Chemoradiotherapy in Cervical Cancer
In a groundbreaking phase Ib clinical trial published in BMC Cancer, researchers have unveiled promising results exploring the combination of ...
POPULAR NEWS
-
Survey Links Indoor Exposures and Childhood Allergic Multimorbidity in Northwest China
-
Researchers Validate Persian Version of the Self-Directed Online Learning Scale
-
Rwanda Study Links AI Tool Gender Gap to Access, Not Skill
-
Exome Sequencing Reveals Gene Candidates in Brazilian Consanguineous Cohort